Kovack Advisors Inc. Buys 313 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Kovack Advisors Inc. boosted its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 3.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,794 shares of the biotechnology company’s stock after acquiring an additional 313 shares during the period. Kovack Advisors Inc.’s holdings in Axon Enterprise were worth $5,226,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Prestige Wealth Management Group LLC boosted its holdings in Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares during the last quarter. New Wave Wealth Advisors LLC bought a new stake in Axon Enterprise in the fourth quarter valued at approximately $40,000. Brooklyn Investment Group acquired a new position in Axon Enterprise in the third quarter valued at approximately $41,000. Y.D. More Investments Ltd acquired a new position in Axon Enterprise in the fourth quarter valued at approximately $45,000. Finally, Planning Capital Management Corp lifted its stake in Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after buying an additional 55 shares during the period. 79.08% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on AXON. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Robert W. Baird boosted their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. The Goldman Sachs Group boosted their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a research report on Wednesday. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $587.38.

Axon Enterprise Stock Up 15.3 %

AXON stock opened at $572.40 on Thursday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company has a market capitalization of $43.65 billion, a price-to-earnings ratio of 147.91, a PEG ratio of 5.17 and a beta of 1.05. Axon Enterprise, Inc. has a fifty-two week low of $265.32 and a fifty-two week high of $715.99. The stock has a fifty day moving average of $613.42 and a 200-day moving average of $522.06.

Insider Transactions at Axon Enterprise

In related news, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the sale, the director now owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. This represents a 3.96 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 8,711 shares of company stock worth $5,631,561. 5.70% of the stock is owned by company insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.